der(16)t(1;16)/der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosis

Genes Chromosomes and Cancer

Volumn 24, Issue 1, 1999, Pages 72-77

  Tsuda, Hitoshi ^a   Takarabe, Teruko ^a   Fukutomi, Takashi ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CHROMOSOME 1; CHROMOSOME 16; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; STRUCTURAL CHROMOSOME ABERRATION;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 16; DNA PROBES; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 0032889648     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199901)24:1<72::AID-GCC10>3.0.CO;2-M     Document Type: Article

References (33)

1. Berger MS, Locher GW, Sauer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE. 1988. Correlation of c-erbB-2 gene amplification and protein expression in human breast cancer with nodal status and nuclear grading. Cancer Res 48:1238-1243.
2. Bièche I, Champème MH, Matifas F, Hacène K, Callahan R, Lidereau R. 1992. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339:139-143.
3. Chen L-C, Neubauer A, Kurisu W, Waldman FM, Ljung B-M, Goodson W III, Goldman ES, Moor D II, Balazs M, Liu E, Mayall BH, Smiths HS. 1991. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci USA 88:847-3851.
4. Cooke HJ, Hindley J. 1979. Cloning of human satellite III DNA: Different components are on different chromosomes. Nucleic Acids Res 6:3177-3179.
5. Dutrillaux B, Gerbault-Seureau M, Zafrani B. 1990. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 49:203-217.
6. Eusebi V, Pich A, Macchiorlatti E, Bussolati G. 1977. Morphofunctional differentiation in lobular carcinoma of the breast. Histopathology 1:301-314.
7. Fisher ER, Gregorio RM, Redmond C, Fisher BG. 1977. Tubolobular invasive breast cancer: A variant of lobular invasive cancer. Hum Pathol 8:679-683.
8. Fukutomi T, Akashi S, Nanasawa T, Yamamoto H. 1995. Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose ACMF with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study. J Surg Oncol 60:242-246.
9. Greig GM, Willard HF. 1989. Human β-satellite DNA: Genomic organization and sequence definition of a class of highly repetitive tandem DNA. Proc Natl Acad Sci USA 86:6250-6254.
10. Greig GM, England SB, Bedford M, Willard HF. 1989. Chromosome-specific alpha satellite DNA from the centromere of human chromosome 16. Am J Hum Genet 45:862-872.
11. Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakamura Y, Takahashi T, Abe T, Inazawa J. 1996. Analysis of numerical aberrations in specific chromosomes by fluorescence in situ hybridization (FISH) as a diagnostic tool in breast cancer. Cancer 77:2064-2069.
12. Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D, Gray JW. 1992. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321-5325.
13. Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M. 1987. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47:311-318.
14. Kaplan EL, Meier P. 1958. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
15. Kokalj-Vokac N, Alemeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. 1993. Two-color FISH characterization of i(1q) and der(1;16) in human breast cancer cells. Genes Chromosomes Cancer 7:8-14.
16. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD. 1988. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. Ann Intern Med 108:14-20.
17. Matsumura K, Kallioniemi A, Kallioniemi O, Chen L, Smith HS, Pinkel D, Gray J, Waldman FM. 1992. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 52:3474-3477.
18. Merlo GR, Venesio T, Bernardi A, Canale L, Gaglia P, Lauro D, Cappa APM, Callahan R, Liscia DS. 1992. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index. Am J Pathol 140:215-223.
19. Moyzis RK, Albright KL, Bartholdi MF, Cram LS, Deaven LL, Hildebrand CE, Joste NE, Longmire JL, Meyne J, Schwarzacher-Robinson T. 1987. Human chromosome-specific repetitive DNA sequences: Novel markers for genetic analysis. Chromosoma 95:375-386.
20. Murphy DS, Hoare SF, Going JJ, Mallon EEA, George WD, Kaye SB, Brown R, Black DM, Keith WN. 1995. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 87:1694-1704.
21. Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, Ott M, Muller-Hermelink HK. 1997. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT) type. Cancer Res 57:3944-3948.
22. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F. 1992. Whole-arm t(1;16)and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5:235-238.
23. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S. 1995. Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12:173-185.
24. Pandis N, Teixeira MR, Adeyinka A, Rizou H, Bardi G, Mertens F, Anderson JA, Bondeson L, Sfikas K, Qvist H, Apostolikas N, Mitelman F, Heim S. 1998. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 22:122-129.
25. Peto P, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39.
26. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. 1990. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335:1171-1174.
27. Sandberg AA, Turc-Carel C, Gemmill RM. 1988. Chromosomes in solid tumors and beyond. Cancer Res 48:1049-1059.
28. Scarff RW, Torloni H. 1968. Histological Typing of Breast Tumours. International Histological Classification of Tumours. No. 2. Geneva: World Health Organization.
29. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
30. Tsuda H, Fukutomi T, Hirohashi S. 1995. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Clin Cancer Res 1:261-267.
31. Tsuda H, Takarabe T, Susumu N, Inazawa J, Okada S, Hirohashi S. 1997. Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. Am J Pathol 151:1027-1034.
32. Willard HF, Waye JS. 1987. Chromosome-specific subsets of human alpha satellite DNA: Analysis of sequence divergence within and between chromosomal subsets and evidence for an ancestral pentameric repeat. J Mol Evol 25:207-214.
33. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G. 1989. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med 320:1047-1054.